Transforming how respiratory diseases are monitored and managed

Chronic respiratory diseases are among the most prevalent and difficult to manage health conditions, among the leading causes of death worldwide and contributing to millions of emergency visits and hospital readmissions each year.  Despite their impact, respiratory symptoms are often under-measured outside the clinic, leaving clinicians without the insight needed to detect potential exacerbations or fully understand how patients respond to treatments in daily life.

Strados Labs was founded to close this gap. Our mission is to transform how respiratory diseases are monitored and managed by offering seamless, objective measurement of symptoms like cough, wheeze, and breathing patterns through innovative technology such as wearable sensors and machine learning. We provide the tools that help life sciences companies improve understanding of treatment response in clinical trials and enable care teams to make earlier, more informed decisions that can prevent avoidable hospitalizations and improve outcomes. Let’s make every breath count. 

Our team came together at a health hackathon hosted by Independence Blue Cross and Thomas Jefferson University. Strados Labs founder, Nick Delmonico, is a patient who has spent time in the ER and the ICU due to asthma and respiratory illness like RSV. He understands the complexity of properly communicating symptoms and pulmonary status remotely. He wanted to build a better way to get this information into the hands of clinicians to avoid adverse respiratory events.

Since 2016, Strados Labs has successfully transformed the RESP Platform from an idea to reality with the help of our dedicated team and partners.